Stella Diagnostics, Inc.
SLDX
$0.049
$0.00922.50%
OTC PK
| 03/31/2012 | 09/30/2011 | 06/30/2011 | 03/31/2011 | ||
|---|---|---|---|---|---|
| Revenue | -- | -104.33% | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -104.33% | -- | -- | |
| Cost of Revenue | -- | -97.72% | -- | -- | |
| Gross Profit | -- | -107.62% | -- | -- | |
| SG&A Expenses | -- | 225.12% | -- | -- | |
| Depreciation & Amortization | -- | -20.00% | -- | -- | |
| Other Operating Expenses | -- | -69.52% | -- | -- | |
| Total Operating Expenses | -- | 134.92% | -- | -- | |
| Operating Income | -- | -387.65% | -- | -- | |
| Income Before Tax | -- | -84.79% | -- | -- | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | -84.79% | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -84.79% | -- | -- | |
| EBIT | -- | -387.65% | -- | -- | |
| EBITDA | -- | -523.28% | -- | -- | |
| EPS Basic | -- | -- | -- | -- | |
| Normalized Basic EPS | -- | -- | -- | -- | |
| EPS Diluted | -- | -- | -- | -- | |
| Normalized Diluted EPS | -- | -- | -- | -- | |
| Average Basic Shares Outstanding | -- | -- | -- | -- | |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |